Skip to main content
翻译进行中 — 您的语言版本正在准备中,目前内容以英语显示。

科学家找到了强生公司新冠疫苗的问题所在

Healthcare
全球
开始于 February 12, 2026

Rare but dangerous blood clotting associated with that vaccine as well as AstraZeneca’s had a genetic cause, according to a new paper

Need to find a specific claim? Search all statements.
🗳️ Join the conversation
5 条陈述待投票 • Your perspective shapes the analysis
📊 Progress to Consensus Analysis Need: 7+ participants, 20+ votes, 3+ votes per statement
Participants 0/7
Statements (7+ recommended) 5/7
Total Votes 0/20
💡 Progress updates live here. Final readiness is confirmed when all three requirements are met.

Your votes count

No account needed — your votes are saved and included in the consensus analysis. Create an account to track your voting history and add statements.

CLAIM 发布者 will Feb 12, 2026
This research underscores the importance of transparency in vaccine safety data to maintain public trust in vaccination efforts.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 发布者 will Feb 12, 2026
While rare, the blood clotting issues associated with these vaccines highlight the need for comprehensive risk assessments in public health.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 发布者 will Feb 12, 2026
The focus on genetic causes may distract from the broader context of vaccine efficacy and the benefits they provide in controlling the pandemic.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 发布者 will Feb 12, 2026
The identification of genetic causes for vaccine-related side effects raises significant concerns about the safety of COVID vaccines.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
Vote to see results
CLAIM 发布者 will Feb 12, 2026
Understanding the genetic basis of blood clotting linked to vaccines can enhance safety and inform future vaccine development.

翻译待处理

Vote options for this statement: agree, disagree, or unsure
Vote to see results

💡 How This Works

  • Add Statements: Post claims or questions (10-500 characters)
  • Vote: Agree, Disagree, or Unsure on each statement
  • Respond: Add detailed pro/con responses with evidence
  • Consensus: After enough participation, analysis reveals opinion groups and areas of agreement

Society Speaks is open and independent. Your support keeps civic discussion free from advertising and commercial influence.

Support us